Orthopedic Surgery and Trauma

Nicolaides, Andrew; Fareed, Jawed; Kakkar, Ajay K.; Comerota, Anthony J.; Goldhaber, Samuel Z.; Hull, Russell D.; Myers, Kelly; Samama, Meyer-Michel; Fletcher, J.; Kalodiki, Evi; Bergqvist, David; Bonnar, J.; Caprini, Joseph A.; Carter, C.; Conard, J.; Eklöf, Bo; Elalamy, Ismaı̈l; Gerotziafas, G.; Geroulakos, George; Giannoukas, A.; Greer, Ian A.; Griffin, Maura; Kakkos, S.; Lassen, Michael R.; Lowe, G. D. O.; Markel, Arie; Prandoni, Paolo; Raskob, Gary E.; Spyropoulos, Alex C.; Turpie, Alexander G. G.; Walenga, Jeanine M.; Warwick, David

doi:10.1177/1076029612474840f

Clin Appl Thromb Hemost

2013

DOI: 10.1177/1076029612474840f

|View full text |Cite

Orthopedic Surgery and Trauma

Andrew Nicolaides¹,

Jawed Fareed²,

Ajay K. Kakkar³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 236 publications

(282 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Anticoagulant therapy for venous thromboembolism prophylaxis in orthopaedic surgery in Japan: The evolving role of NOACs

Fuji¹

2016

Current Orthopaedic Practice

View full text Add to dashboard Cite

Venous thromboembolism (VTE) is a serious complication of major orthopaedic surgery of the lower limbs. Prophylaxis therapy for VTE is important for patients who undergo orthopaedic surgery; pharmacological prophylaxis is one of the more effective therapies. In addition to the traditional anticoagulants, such as warfarin and heparin, non-vitamin K antagonist oral anticoagulants (NOACs) with VTE prophylaxis properties have recently been developed and provide a convenient option for thromboprophylaxis. Edoxaban, a direct factor Xa inhibitor, is the only NOAC approved in Japan for prophylaxis of VTE in patients undergoing lower limb orthopaedic surgery. The efficacy and safety of edoxaban for primary VTE prevention after lower limb orthopaedic surgery has been demonstrated in several phase 3 clinical studies, along with Japanese postmarketing surveillance. This article reviews Japanese studies in the area of VTE prophylaxis after orthopaedic surgery and provides an up-to-date status of the treatment including NOACs in orthopaedic surgery.

show abstract

Anticoagulant therapy for venous thromboembolism prophylaxis in orthopaedic surgery in Japan: The evolving role of NOACs

Fuji¹

2016

Current Orthopaedic Practice

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Orthopedic Surgery and Trauma

Cited by 1 publication

References 236 publications

Anticoagulant therapy for venous thromboembolism prophylaxis in orthopaedic surgery in Japan: The evolving role of NOACs

Anticoagulant therapy for venous thromboembolism prophylaxis in orthopaedic surgery in Japan: The evolving role of NOACs

Contact Info

Product

Resources

About